Efficacy of a Digital Biofeedback System for Home-based Rehabilitation After Total Joint Replacement
Launched by SWORD HEALTH, SA · Aug 23, 2018
Trial Information
Current as of October 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical and imaging evidence of hip/knee osteoarthritis
- • Indication for total hip/knee replacement according to the patient´s orthopedic surgeon
- • Ability to walk unaided, with unilateral or bilateral support
- • Availability of a carer to assist the patient after surgery
- Exclusion Criteria:
- • Patients admitted for revision of total hip/knee replacement
- • Contralateral hip or knee osteoarthritis severely limiting patient mobility and ability to comply with a rehabilitation program
- • Aphasia, dementia or psychiatric comorbidity interfering with the communication or compliance to the rehabilitation process
- • Respiratory, cardiac, metabolic or other condition incompatible with at least 30 minutes of light to moderate physical activity
- • Major medical complications occurring after surgery that prevent the discharge of the patient within 10 days after the surgery
- • Other medical and/or surgical complications that prevent the patient from complying with a rehabilitation program
- • Blind and/or illiterate patients
About Sword Health, Sa
Sword Health, S.A. is a leading digital health company dedicated to transforming musculoskeletal care through innovative technology and evidence-based solutions. With a focus on delivering personalized rehabilitation programs, Sword Health combines advanced digital platforms with virtual physical therapy to empower patients in their recovery journey. By leveraging data analytics and machine learning, the company aims to optimize treatment outcomes while enhancing patient engagement and accessibility. Sword Health is committed to advancing healthcare through clinical research and partnerships, ensuring the highest standards of care for individuals with musculoskeletal conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto, Portugal
Patients applied
Trial Officials
Fernando D Correia, MD
Principal Investigator
Sword Health, SA
Rosmaninho Seabra, MD
Study Chair
Hospital da Prelada
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials